List of Sessions - ACP CME On-Demand: 2026 Hospital Medicine Recordings

Speaker: Nidhi Rohatgi, MD, MS

• Should we work up transient atrial fibrillation?
• Are we moving from rate control to rhythm control for atrial fibrillation?
• Should we anticoagulate a first episode of transient atrial fibrillation?
• Is heparin bridging for atrial fibrillation overused?

Speaker: Biff F. Palmer, MD, FACP

1. Incidental lab finding: Sodium 13
   • Now what?
2. HCO3 18: Should I panic?

Speaker: Jose R. Maldonado, MD, FACLP

• How can acute psychosis from a psychiatric condition be distinguished from delirium?
• What medical testing is indicated for acute psychosis?
• How can patients with underlying psychiatric conditions be best managed and supported during medical admissions?

Speaker: Mikhail Y. Akbashev, MD, FACP

• How should we decide among anticoagulants and thrombolytics for acute venous thromboembolism?
• Which patients with new pulmonary embolism can be sent home from the emergency department?
• When is it reasonable not to anticoagulate?
• How should we manage patients with thrombosis and bleeding?
• How should we manage patients with thrombosis while anticoagulated?

Speaker: Melissa B. Weimer, DO, MCR, DFASAM

• How can the stability of an outpatient addiction treatment plan be continued when patients are admitted to the hospital?
• What is the current evidence for initiating medications for addiction treatment during hospital admission, and how can transition to outpatient care be facilitated?
• How can interdisciplinary teams be structured to best support patient safety and autonomy in the inpatient setting?

Speaker: Moises Auron, MD, FACP, FAAP, SFHM, FRCP(Lon), FRCPCH

• How can the transition from pediatric to adult outpatient care or hospitalization be facilitated for patients graduating from pediatric care?
• What are important clinical pearls for the care of adult patients with congenital or genetic conditions, such as congenital heart disease, sickle cell disease, and cystic fibrosis?
• When do patients with complex congenital conditions need to be cared for at, or transferred to, a tertiary center?

Moderator: Barbara J. Turner, MD, MSEd, MACP
Panelists: Stephanie Chang, MD, Member • Christina C. Wee, MD, MPH, FACP

• Participants will become aware of recent studies with implications for internal medicine practice, research, and education.

Speaker: Brian F. Mandell, MD, PhD, MACP, MACR

• What are the minimum clinical requirements to consider antiphospholipid syndrome (APS)?
• What are the clinical criteria for the diagnosis of APS?
• What are the laboratory criteria for the diagnosis of APS?

Speaker: Stanislav Henkin, MD, MPH

• How do I manage antiplatelet therapy in patients after a percutaneous coronary intervention (PCI)?
• How do I manage antiplatelet therapy in patients requiring anticoagulation?
• How do I assess bleeding risk in patients receiving dual-antiplatelet therapy?

Speaker: Kelley Branch, MD, MSc, Member

• What are the cardinal symptoms of severe aortic stenosis?
• What is the appropriate evaluation and time for referral for aortic stenosis?
• As an internal medicine physician, how can I best serve my patients with a potential or existing prosthetic aortic valve?

Speaker: Tyler J. Loftus, MD, PhD

• What artificial intelligence (AI) tools are currently available to help me and/or my hospitalized patients?
• Are there evidence-based outcomes for AI use in acute medical illness?
• What are examples of AI's anticipated uses in hospital medicine?
• What are the risks of AI in the inpatient setting?

Speaker: Kenneth W. Goodman, PhD, FACMI, FACE

• How can AI be ethically implemented in health care with concerns over data privacy, patient consent, and algorithmic transparency?
• What are frameworks and guidelines that can help ensure ethical and legal AI practices in health care?
• What is the potential for bias in AI algorithms, including how biased training data can lead to disparities in health care outcomes?
• What is the role of health care professionals in advocating for ethical AI practices and ensuring that AI tools are used to improve, not hinder, equitable patient care?
• What are the consequences of widespread reliance of AI tools for diagnosis and prognosis?

Speaker: Adam Rodman, MD, MPH, FACP

• What are some case studies that demonstrate successful implementation of artificial intelligence (AI) in primary care, highlighting the impact on patient care and staff productivity?
• What are the various applications of AI tools in primary care, such as clinical decision support, predictive analytics, patient triage, and administrative automation to improve efficiency, accuracy, and patient outcomes in the primary care setting?
• What are best practices for integrating AI tools while maintaining patient-centered care and ensuring compliance with regulations and ethical guidelines?

Speaker: Donna M. Miller, MD, Member

• Are goals of care different for frail older patients?
• How do you assess fitness for surgery in frail patients?
• What strategies can we use to improve outcomes in frail patients in the hospital or undergoing surgery?

Speaker: Nicholas J. Kenyon, MD, MAS, FACP

• What are the different bronchodilator and steroid inhaler types for asthma?
• What are the latest recommendations from the Global Initiative for Asthma?
• What are the data to support the use, efficacy, and cost of newer biologic treatments?

Speaker: James A.S. MuldowneyIII, MD

• What are the diagnostic criteria and basic therapies for postural tachycardia syndrome (POTS)?
• What is the management of patients with orthostatic hypotension and/or supine hypertension?
• How do I evaluate and manage a patient with vasodepressor syncope?

Speaker: David P. Serota, MD, MSc

• What is current best practice for treating gram-negative rod bacteremia?
• What factors play into determining the length of treatment in bacteremia, and how is treatment length impacted by the presence of implanted medical devices and hardware?
• Which patients with bacteremia need additional imaging?
• Can oral antibiotics be used to treat bacteremia?
• What strategies can be used to treat bacteremia among persons who inject drugs?

Speaker: Vera P. Luther, MD, MS

• What are the current recommendations for vaccination and other pharmacologic preventive strategies among adults for respiratory syncytial virus (RSV), influenza, and COVID-19 infections?
• What treatment and point-of-care testing options are available?
• How effective are the available prevention and treatment options?

Speaker: Julia H. Arnsten, MD

• How does cannabis withdrawal present?
• How does regular cannabis use impact acute and chronic illness?
• How does regular cannabis use impact pain control?

Director: Howard Weitz, MD, MACP, FRCP (Lond.), FACC
Co-Director: Gregary D. Marhefka, MD, FACP, FACC
Panelists: Kelley Branch, MD, MSc, Member • Daniel Frisch, MD • John McPherson, MD, FACP, FACC • Geno J. Merli, MD, MACP, FHM, FSVM • Meghan Nahass, MD • Andrew C. Peters, MD, FACP, FACC, FASE • Indranee Rajapreyar, MD

Speaker: Harold M. Szerlip, MD, MACP, FCCP, FASN, FNKF

• What is the cause of acute kidney injury in acute decompensated heart failure?
• What is diuretic resistance, and how do I overcome it?
• What do I do if renal function worsens with decongestive therapy?

Speaker: Michael A. Steinman, MD, FACP

• How do we approach deprescribing for older patients? What are tools to assist with deprescribing?
• How can clinicians identify potentially inappropriate medications?
• Once a potentially inappropriate medication is identified, what safer therapies can clinicians use instead?

Speaker: Douglas S. Paauw, MD, MACP

• What are the impacts of supply chain disruptions on medication availability?
• What are some of the most important side effects discovered this year?
• What is the best way to handle prior authorizations?

Speaker: Robert O. Roswell, MD, FACP, FACC

• Who can be discharged home from the emergency department?
• Who should get a coronary computed tomography angiography (CCTA) versus stress test versus left heart catheterization?
• Should medications for primary or secondary prevention be empirically added before discharge?

Speaker: Mark C. Bicket, MD, PhD, FASA

• How should pain type and pathophysiology guide opioid and non-opioid treatment selection?
• What do current data show on long-term opioid risks and benefits, and how should this shape prescribing?
• What is the role of medical cannabis, naltrexone, and non-pharmacological approaches in light of new guidelines and policies?

Speaker: Yasmin G. Hernandez-Barco, MD

• What are the clinical features and diagnostic criteria for chronic pancreatitis?
• How to control pain in chronic pancreatitis?
• What are the challenges in diagnosis and management of exocrine pancreatic insufficiency?
• How to monitor additional complications such as diabetes, micronutrient deficiencies, and metabolic bone disease?

Speaker: Stacy Street, MD, CWSP, MSHA, FACS

• What are the fundamental principles of chronic wound assessment and management that internal medicine physicians should apply in both outpatient and inpatient settings?
• How can internal medicine physicians choose appropriate chronic wound care treatments and dressings based on the type of wound and its healing stage while considering the patient's overall health status and care setting?
• When should internal medicine physicians manage chronic wounds independently, and when is it necessary to involve specialists or refer to wound care centers?

Speaker: Sofia Simona Jakab, MD

• How has the epidemiology of liver disease in the inpatient setting shifted?
• What are the most sensitive, specific, and practical ways to accurately diagnose new cirrhosis?
• What elements of high-value care are commonly missed in the hospital?

Moderator: John B. Bundrick, MD, MACP
Co-Moderator: Christopher R. Stephenson, MD, MHPE, FACP
Panelists: Charles Reznikoff, MD, FACP, FASAM • William F. YoungJr., MD • William F. Young Jr., MD

• Test your clinical acumen by answering challenging patient management questions faced in practice.
• Compare your critical thinking with that of your colleagues.
• Amass a rich collection of "pearls" that can be applied to patient care.

Moderator: John B. Bundrick, MD, MACP
Panelists: Amy S. Oxentenko, MD, MACP, MACG, AGAF • Christopher R. Stephenson, MD, MHPE, FACP

• Test your clinical acumen by answering challenging patient management questions faced in practice.
• Compare your critical thinking with that of your colleagues.
• Amass a rich collection of "pearls" that can be applied to patient care.

Moderator: John B. Bundrick, MD, MACP
Co-Moderator: Christopher R. Stephenson, MD, MHPE, FACP
Panelists: Randall S. Edson, MD, MACP, FIDSA, FRCP-London • Carrie (Beth) Robertson, MD

• Test your clinical acumen by answering challenging patient management questions faced in practice.
• Compare your critical thinking with that of your colleagues.
• Amass a rich collection of "pearls" that can be applied to patient care.

Moderator: Avital Y. O'Glasser, MD, FACP, SFHM, DFPM
Panelists: Ross W. Hilliard, MD, FACP • Abigail May Khan, MD, MSCE • Stephanie Kim, MD, MPH

• Segment A: Diabetes
  • 1. What is the current landscape of devices for diabetes care?
  • 2. How can the data from diabetes wearables be included in medical decision making?
  • 3. How can patient autonomy versus inpatient safety be balanced for patients with diabetes-care devices?
• Segment B: Cardiology
  • 1. What is the current landscape of devices for cardiology care?
  • 2. How can the data from cardiology wearables be included in medical decision making?
  • 3. What are logistical and ethical challenges with turning off cardiac devices?
• Segment C: Neuromuscular
  • 1. What is the current landscape of devices for neuromuscular symptoms?
  • 2. How can continued use of electronic devices be supported in the inpatient setting, and when do device settings need to be adjusted based on the reason for admission?
  • 3. What common hospital- or outpatient-based interventions potentially risk damaging device function?

Speaker: Eric Widera, MD, FACP

• What is the current evidence for the use of disease-modifying agents for mild cognitive impairment?
• What is a high-value approach to the evaluation of a patient with suspected mild cognitive impairment, including biomarker testing?
• When is it appropriate to refer a patient to a neurologist for further diagnosis and management?

Co-Presenters: Geno J. Merli, MD, MACP, FHM, FSVM • Howard Weitz, MD, MACP, FRCP (Lond.), FACC

• Join the Annals Consult Guys as they address a variety of clinical issues while using humor to deliver educational pearls related to the practice of internal medicine.

Speaker: David Spragg, MD

• Do any patients benefit from atrial fibrillation (AF) ablation as the initial treatment strategy?
• Which patients are appropriate for left atrial appendage closure?
• How does age play a role in anticoagulation decisions?
• What other patient factors play a role in anticoagulation decisions?

Speaker: Stephanie Kim, MD, MPH

• When should an internal medicine physician consider ordering continuous glucose monitoring (CGM)?
• What are the clinical benefits of CGM for patients with diabetes?
• What is a systematic method of interpreting CGM data?

Speaker: Karen C. Bloch, MD, MPH, FACP

• What is the current epidemiology of vector-borne infections in the Unites States in this era of climate change?
• What are the most clinically significant vector-borne infections?
• What diagnostic testing and treatment are recommended for these infections?

Speaker: Sabrina Taldone, MD, MBA, Member

• What types of consumer-driven tests, ranging from genetic analyses to assessments of nutritional and environmental exposures, are most commonly presented to primary care physicians, and what are the typical pitfalls and interpretation challenges?
• As patients increasingly track their health through wearables (e.g., Fitbit and Apple Watch), what trends should primary care providers be aware of, and how can they critically evaluate and integrate these data?
• How can clinicians determine which aspects of patient-generated data are supported by robust evidence, enabling them to separate useful insights from nonvalidated or misleading findings?
• What strategies can help primary care physicians incorporate relevant patient-generated results into clinical practice, effectively communicate uncertainties or limitations, and maintain trust while discouraging reliance on questionable testing?

Speaker: Eric Widera, MD, FACP

• What are the most common causes and presentations of delirium in the hospital setting?
• What should a hospitalist know about the management and prevention of delirium, including the misuse of antipsychotics?
• What implications does an episode of inpatient delirium have for postdischarge cognitive trajectory?

Speaker: David A. D'Alessio, MD

• How do GLP-1 agonists cause weight loss and loss of appetite? 
• What is the mechanism and role for GLP agonists in the treatment of addictive disorders for overweight/obese patients with prediabetes or diabetes?
• What are the mechanism for the cardioprotective and nephroprotective benefits of GLP-1 analogs?
• What is the role for GLP-1 agonists in the treatment of male and female reproductive disorders such as hypogonadism, oligomenorrhea, or infertility?
• Beyond the effects of weight loss, are the specific qualitative and quantitative effects of GLP-1 agonists on bone or muscle?

Moderator: Luis Isea Mercado, MD, FACP
Panelists: Megan Hiles, MD, MBA, FACP • Kizer Stovall, MD, FACP • Kizer Stovall, MD, FACP

• Discuss critical steps or factors to consider when evaluating whether a particular opportunity aligns with your professional goals and personal values.
• Identify practical tips on how early career physicians can seek out and effectively use mentors and professional networks to facilitate their own transitions.
• Identify strategies effective for quickly acclimating to new professional environments and excelling in those roles.

Speaker: Bradley A. Sharpe, MD, SFHM

• Which new medications should be on the differential diagnoses for electrolyte abnormalities?
• Which patients are at highest risk for refeeding syndrome?
• What is the latest evidence for electrolyte repletion for patients with cardiac disease?
• Do we overreplete potassium, magnesium, and phosphorus in hospitalized patients?
• What is a cost-effective approach to electrolyte management in the hospital?

Speaker: Eve Bloomgarden, MD

• How can hyperthyroidism or hypothyroidism be diagnosed and managed in the inpatient setting?
• What are practical management strategies for fragility fractures in the hospital (e.g., medications and transitions of care)?
• Which patients should receive stress-dose steroids based on their risk for adrenal insufficiency?
• How should we approach inpatient management of thyroid storm or myxedema coma?
• Inpatient pituitary management: perioperative and postoperative management recommendations.

Speaker: Ivor Douglas, MD, FRCP (UK)

• Is early use of vasopressors safe and effective for septic shock?
• Can I give vasopressor agents through a peripheral IV catheter, or do I always need a central line?
• What is the evidence that supports early use of vasopressors for septic shock?

Speaker: Tanvi Dhere, MD

• What diagnostic advances exist for patients with unclear sources of gastrointestinal (GI) bleeding?
• Which patients with pancreatitis need more imaging than just the CT ordered in the emergency department?
• What are emerging testing and treatment opportunities for Clostridioides difficile (C diff) infection?

Speaker: Darcy Wooten, MD, MS

• What are the latest recommendations and options for HIV preexposure prophylaxis (PrEP) and postexposure prophylaxis (PEP)?
• What are the recommendations for doxycycline PEP?
• What are the current screening recommendations for patients receiving PrEP and PEP?
• How can clinicians lead inclusive, compassionate discussions and ensure equitable access to PrEP and PEP?
• What strategies should clinicians use to retain patients in care and adhere to monitoring recommendations?

Speaker: Nosheen Reza, MD, MS

• What is the long-term management of patients with a history of heart failure with recovered ejection fraction?
• Do specific causes of heart failure with reduced ejection fraction (HFrEF) require a different long-term approach?
• When are patients "out of the woods" when they are clinically stable?

Speaker: Ebrahim Barkoudah, MD, MPH, FACP, SFHM

• When during the hospital stay should we start the individual components of goal-directed medical therapy (GDMT)?
• What are evidence-based strategies to monitor the daily effectiveness of intravenous (IV) diuresis in the hospital?
• When should we continue versus stop IV diuresis in the setting of worsening renal function?
• What is the role of sodium and fluid restriction when the patient is hospitalized?
• What is the care model and care transition at discharge for heart failure?

Speaker: Leila Kia, MD

• What questions should be asked of patients with dysphagia?
• What are the high-yield and "can't-miss" referrals for upper gastrointestinal evaluation?
• What is the optimal diagnostic evaluation for patients with symptoms of an upper gastrointestinal motility disorder?

Director: James Newman, MD, MHA, MACP
Co-Director: Rachel Hammer, MD, MFA, Member
Faculty: Adrian Baudy IV, MD, MBA • Deanne T. Kashiwagi, MD, FACP, SFHM • A. Scott Keller, MD, MS, FACP • Pramita Kuruvilla, MD, FAAFP, HEC-C • Sherry Liang, MD • Daniel Minter, MD

Speaker: Ayako Mayo, MD

• Who are good candidates for hospital at home?
• How do we monitor these patients remotely?
• What evidence exists for the benefits, risks, and costs of hospital at home?

Speaker: Jordana Cohen, MD, MSCE

• What is the goal blood pressure?
• How do I get there?
• What's new in the management of hypertension?

Speaker: Adrian Vella, MD

• What medications commonly cause hypoglycemia?
• What is the initial evaluation of hypoglycemia?
• When should an internal medicine physician refer a patient with possible hypoglycemia to an endocrinologist (or initiate a full diagnostic evaluation) for endogenous hyperinsulinemia or non–islet cell tumor?

Speaker: Emerson Chen, MD

• How have immunomodulators shifted the cancer care landscape, especially in terms of reasons to need hospital admission for cancer-related care?
• How should immunomodulators be managed around transitions of care when patients are admitted for nononcologic reasons?
• What are the most common severe adverse effects of immunotherapy that result in hospitalization?
• What adverse effects of immunomodulators must inpatient clinicians be aware of even if they are not the cause for admission?

Speaker: Moises Auron, MD, FACP, FAAP, SFHM, FRCP(Lon), FRCPCH

• What are the reversal agents for anticoagulation, and when are they clinically indicated?
• Beyond platelets, what else can I transfuse to stop bleeding?
• When do I order bleeding diathesis labs?
• What patients should be considered for intravenous (IV) iron infusion, and should we avoid iron in patients with sepsis?

Speaker: Sara C. Markley Webster, MD

• In which patients should we consider continuing outpatient diabetes medications, including newer oral medications and newer formulations of insulin, during their admission?
• Which patients receiving sodium–glucose cotransporter-2 (SGLT2) are most at risk for euglycemic diabetic ketoacidosis (EDKA), and can it be distinguished from alcohol or starvation ketosis? Is it safe to continue SGLT2 in the hospital in some patients?
• For a new diagnosis of diabetes, how do we decide which medications to start at discharge?

Speaker: Dennis Chang, MD

• What is a practical approach to the latest perioperative guidelines?
• Should surgery ever be delayed for cardiac testing?
• What patient optimization options exist in the inpatient setting that can prevent postoperative complications?

Speaker: Kevin F. Kwaku, MD, PhD

• How do I evaluate a patient with frequent premature ventricular contractions (PVCs)?
• When is a pacemaker indicated in a patient with bradycardia?
• How should I use ambulatory heart monitoring and other wearable devices in patients with palpitations?

Speaker: Zaldy S. Tan, MD, MPH, FACP

• What is "mild behavioral impairment" in patients with dementia?
• What are the behaviors we should target to reduce caregiver burden and functional decline in patients with dementia?
• How do we use pharmacologic and nonpharmacologic strategies for behavior management?

Speaker: Modele O. Ogunniyi, MD, MPH, FACP, FACC, FAHA

• What is the current blood pressure treatment goal for pregnant women with hypertension?
• How should I evaluate patients with resistant hypertension?
• How should I manage hypertension in older adults?

Speaker: Robert M. Centor, MD, MACP

• What are common sources of uncertainty in clinical reasoning, such as incomplete information, ambiguous test results, and complex patient presentations?
• What are techniques for improving clinical reasoning in uncertain situations, such as probabilistic thinking, Bayesian analysis, and shared decision making with patients?
• What are effective communication strategies to convey uncertainty to patients and set realistic expectations about diagnosis and treatment?

Speaker: Kevin Weber, MD, MHA

• What distinguishes migraine from other common and uncommon headache disorders, and how can clinicians recognize atypical migraine presentations?
• What are the best practices in migraine treatment that consider treatment effectiveness, side effects, and accessibility for patients?
• What steps should be taken when a patient with a presumed migraine diagnosis does not respond to standard treatments?

Speaker: Linda Peng, MD

• What are the latest data on oral antibiotic treatment and surgical options for endocarditis or osteomyelitis?
• How can treatment opportunities for hepatitis C be identified in the inpatient setting and then transitioned to the outpatient setting?
• When should alcohol use disorder be on the differential diagnoses for neurocognitive symptoms?
• What are diagnostic and management options for methamphetamine and alcohol-induced cardiac pathologies?

Speaker: R. Campbell Garland, DO, Member

• How has diagnosis and classification changed?
• How have novel therapies changed prognosis?
• Is cure possible?

Speaker: Samira S. Farouk, MD

• When does acute kidney injury need an inpatient evaluation?
• What are the current criteria for inpatient initiation of dialysis?
• How can the inpatient clinician best manage the hospitalized patient who received home hemodialysis (HD) or peritoneal dialysis (PD)?

Speaker: Madina Tugizova, MD

• How does one differentiate the most common neuromuscular conditions encountered in the hospital?
• What inpatient-related complications are patients with neuromuscular diseases at risk for?
• How are emerging treatment options shifting the clinical landscape for neuromuscular diseases?

Speaker: Gerald W. Smetana, MD, MACP

• Which newly approved medications are likely to be prescribed by internal medicine physicians?
• What are recent medications that have transitioned to generic status and the implications for cost, accessibility, and insurance coverage?
• What side effects of newly approved medications should internal medicine physicians be aware of?

Moderator: Christine Laine, MD, MPH, FACP
Panelists: John A. Batsis, MD, FACP, AGSF, FGSA, FTOS • Carolyn J. Crandall, MD, MS, MACP • Ashok Reddy, MD, MSc, Member

• Authors of three selected articles to be published during the Internal Medicine Meeting will present a 10-minute overview of their article.

Speaker: David S. Seres, MD, ScM, PNS, DFASN, FASPEN

• How can primary care physicians identify individuals and diets at risk for nutritional deficiency or malnutrition, including those living in food deserts, and what are the key strategies to screen and counsel these patients within limited time constraints?
• Who are the key stakeholders in setting nutrition guidelines (including federal agencies, medical societies, and the wellness industry), and what is the evidence base for high-value nutritional screening and interventions?
• How should primary care physicians respond when patients bring in functional medicine lab work related to diet and nutrition?

Speaker: Erin Camac, DO, FCCP, ATSF

• Are antibiotics always necessary for chronic obstructive pulmonary disease (COPD) exacerbations?
• How prevalent is obesity as a cause of restrictive physiology or chronic dyspnea?
• What tests should be considered for the patient with chronic hypercarbic and/or hypoxic respiratory failure of unclear cause?

Speaker: Levanto G. Schachter, DO, MS

• What oncologic emergencies must the hospitalist be prepared to diagnose in the inpatient setting?
• What are diagnostic challenges regarding oncologic emergencies?
• What are the treatment options and best practices for oncologic emergencies?

Speaker: Eduardo Bruera, MD, MACP

• What are the latest advances in symptom management in palliative care that can be applied in clinical practice by both palliative medicine physicians and primary care physicians?
• How can primary care physicians integrate individualized advance care planning with their patients in a busy practice setting?
• For patients in the inpatient setting, how can hospitalists best assess goals of care in the context of new serious illness and/or clinical deterioration?

Speaker: Joanna M. Bonsall, MD, PhD, FACP

• Which patients with community-acquired pneumonia (CAP) should receive broad-spectrum antibiotics for multidrug-resistant organisms?
• Which patients with pneumonia should receive steroids for bacterial pneumonia?
• Is there a role for procalcitonin in diagnosing or managing pneumonia?

Speaker: Arun Jesudian, MD

• What are the health care maintenance considerations for patients with cirrhosis (e.g., vaccines, diet, lifestyle, and screening)?
• What do I do when my patient with cirrhosis needs elective surgery?
• When do I refer my patient with cirrhosis to liver transplant (update in Model for End-Stage Liver Disease [MELD] and organ allocation)?

Speaker: Christin B. DeStefano, MD, FACP

• Which procedures require no prior intervention?
• Can an elevated international normalized ratio (INR) from significant liver disease be corrected? Should it be?
• Can a low platelet count from significant liver disease be corrected? Should it be?
• How are direct oral anticoagulants (DOACs) managed before and after procedures?

Speaker: Mark E. Mikkelsen, MD, MSCE

• What are the long-term effects of critical illness?
• How do you promote recovery from critical illness and avoid readmission?
• What lessons can be learned from post–intensive care unit interventions?

Speaker: Paul Armstrong Hill, MD, MPH, MS

• How common are incidentalomas of the liver, kidney, and pancreas on routine abdominal imaging, and is it important for internal medicine physicians to follow up on these findings?
• Which specific imaging features or patient history factors should prompt immediate additional imaging for these lesions, and what methods are most appropriate for further characterization?
• For lesions that remain indeterminate after initial assessment, what criteria should guide the selection of follow-up method, the appropriate interval between studies, and the determination of when it is safe to discontinue surveillance imaging?

Speaker: John A. Batsis, MD, FACP, AGSF, FGSA, FTOS

• What is sarcopenic obesity, and how do we identify this in our older patients?
• What are the consequences of sarcopenic obesity in older adults?
• Are there management strategies for sarcopenic obesity? Does weight loss help or hurt? Should weight loss drugs be used in older patients?

Speaker: Kevin Piro, MD, FACP

• What history, exam, and point-of-care ultrasound (POCUS) findings help us distinguish cardiogenic shock from other common causes of shock, including the use of POCUS?
• How can we identify the different stages of cardiogenic shock, and how does this influence management?
• How can internal medicine physicians recognize mixed patterns of shock?

Speaker: Jennifer Rasmussen-Winkler, MD, FAHA

• Which stroke mimic presentations to look for?
• Which stroke presentations are commonly missed?
• Who should or should not receive thrombolytics and/or endovascular therapy?
• What emerging therapies are coming for patients with stroke?

Speaker: Daniel D. Dressler, MD, MSc, MACP, MHM

• Which patients presenting to the emergency department with syncope require hospitalization, and who can receive work-up in the outpatient setting?
• What is the appropriate work-up for a patient admitted for syncope, and which symptoms prompt specific diagnostic tests?
• When discharging a patient with syncope, how can pending or additional testing opportunities be triaged at the transition of care?

Speaker: Noelle A. Rolle, MBBS, FACR

• What are the current criteria for diagnosing lupus?
• What tests/studies should be ordered, and how should they be interpreted while waiting to see a rheumatologist?
• What are current and new therapies for lupus?

Speaker: Cynthia M. Stonnington, MD

• How can physicians effectively communicate with and care for patients when they disagree about the plan of care?
• How can physicians recognize and manage their own countertransference reactions to improve therapeutic outcomes?
• What are the best practices for establishing and maintaining boundaries with patients who present complex interpersonal dynamics or psychological needs?
• How do physicians navigate disagreements in care in an era of patient satisfaction scores and online patient reviews?

Speaker: Walter S. Dunn, MD, PhD

• What is the current role of psychedelics in the treatment of resistant mental health disorders, and what evidence supports their use in clinical practice?
• How can primary care physicians identify patients who may benefit from referral to consider psychedelics?
• What are the potential risks, as well as the legal and ethical considerations, associated with prescribing psychedelics?

Speaker: Ryan D. Mire, MD, MACP

• Identify strategies for assessing and negotiating physician contracts.
• Identify tools and resources to support physician contract negotiation and renegotiation efforts.
• Review how to locate physician compensation data and use the data during negotiations to help secure a fair contract.
• Identify ACP resources that support physicians during the contract negotiation process.

Moderator: Jason Williams, MD, Member
Panelist: Trevor Jensen, MD

• What diagnoses have point-of-care ultrasound (POCUS) been proved to aid in with regard to clinical reasoning and diagnostic decision making?
• What are the sensitivity and specificity of some common physical exam maneuvers, and how does this compare to POCUS?
• Are there some physical exam maneuvers that can be abandoned in the modern POCUS era?
• How difficult are these POCUS exam maneuvers to learn?

Presenter: Alison L. Bailey, MD

• Presentation of 6 to 12 papers published during the past 12 to 15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Stephen M. Pastores, MD, MACP, FCCP, MCCM

• Presentation of 6 to 12 papers published during the past 12 to 15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Presenter: Annie Massart, MD

• Presentation of 6 to 12 papers published during the past 12 to 15 months that, in the view of the presenter, have made the most difference in the practice or understanding of the subspecialty.

Speaker: Jasmine R. Marcelin, MD, FACP

• When should urinalysis and culture be performed, and how are they interpreted?
• What treatment is recommended for simple versus complicated urinary tract infections (UTIs)?
• Are all oral agents equal in the management of bacteremia from a urinary source?

Speaker: Christian Cable, MD, MHPE, MACP

• Was vaccine-induced thrombocytopenia with thrombosis (VITT) new?
• How did VITT further understanding of heparin-induced thrombocytopenia (HIT)?
• How is HIT managed?

Speaker: Bradley A. Sharpe, MD, SFHM

• What are the evidence-based strategies for accurate volume status assessment?
• What is the optimal fluid choice for patients with hypovolemia?
• What is the difference between volume-tolerant versus volume-responsive patients?
• What are the evidence-based indications for albumin?
• What are the indications for maintenence fluids and how should they be ordered?
• What is the evidence for point-of-care ultrasound in volume status assessment and management?